A mouse model for SARS-CoV-2-induced acute respiratory distress syndrome
2021 · Signal Transduction and Targeted Therapy · 632 citations
https://doi.org/10.1038/s41392-020-00451-w
Y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
3.7K
Citations
22
h-index
30
i10-index
Yun Yang is an academic researcher from Chinese Academy of Medical Sciences & Peking Union Medical College. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Long-Term Effects of COVID-19. The author has an h-index of 22, co-authored 45 publications.
ORCID: 0000-0002-9986-5930Papers by this author
worksCircular RNA vaccines against SARS-CoV-2 and emerging variants
2022 · Cell · 562 citations
https://doi.org/10.1016/j.cell.2022.03.044
Comparison of nonhuman primates identified the suitable model for COVID-19
2020 · Signal Transduction and Targeted Therapy · 236 citations
https://doi.org/10.1038/s41392-020-00269-6
The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys
2021 · Signal Transduction and Targeted Therapy · 130 citations
https://doi.org/10.1038/s41392-021-00591-7
A novel nitro-dexamethasone inhibits agr system activity and improves therapeutic effects in MRSA sepsis models without antibiotics
2016 · Scientific Reports · 23 citations
https://doi.org/10.1038/srep20307
Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern
2022 · Signal Transduction and Targeted Therapy · 20 citations
https://doi.org/10.1038/s41392-022-00920-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat